Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version). Issue 4 (22nd February 2022)
- Record Type:
- Journal Article
- Title:
- Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version). Issue 4 (22nd February 2022)
- Main Title:
- Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)
- Authors:
- Kudo, Masatoshi
Ikeda, Masafumi
Ueshima, Kazuomi
Sakamoto, Michiie
Shiina, Shuichiro
Tateishi, Ryosuke
Nouso, Kazuhiro
Hasegawa, Kiyoshi
Furuse, Junji
Miyayama, Shiro
Murakami, Takamichi
Yamashita, Tatsuya
Kokudo, Norihiro - Abstract:
- Abstract: Response Evaluation Criteria in Solid Tumors (RECIST) is inappropriate to assess the direct effects of treatment on hepatocellular carcinoma (HCC) by locoregional therapies, such as radiofrequency ablation or transarterial chemoembolization. Therefore, establishment of response evaluation criteria solely devoted to HCC is needed in clinical practice, as well as in clinical trials of HCC treatment, such as systemic therapies, which cause necrosis of the tumor. Response Evaluation Criteria in Cancer of the Liver (RECICL) was revised in 2021 by the Liver Cancer Study Group of Japan based on the 2019 version of RECICL, which was commonly used in Japan. The major revised points of the RECICL 2021 is inclusion of RECIST version 1.1 and modified RECIST as response evaluation criteria in systemic therapy for HCC. We hope this new treatment response criteria, RECICL, proposed by the Liver Cancer Study Group of Japan will benefit the HCC treatment response evaluation in the setting of daily clinical practice and clinical trials as well, not only in Japan, but also internationally.
- Is Part Of:
- Hepatology research. Volume 52:Issue 4(2022)
- Journal:
- Hepatology research
- Issue:
- Volume 52:Issue 4(2022)
- Issue Display:
- Volume 52, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 4
- Issue Sort Value:
- 2022-0052-0004-0000
- Page Start:
- 329
- Page End:
- 336
- Publication Date:
- 2022-02-22
- Subjects:
- hepatocellular carcinoma -- Liver Cancer Study Group of Japan -- modified RECIST -- response evaluation criteria in cancer of the liver (RECICL) -- response evaluation criteria in solid tumors (RECIST)
Liver -- Diseases -- Periodicals
Liver Diseases -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09284346 ↗
http://firstsearch.oclc.org/journal=1386-6346;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1872-034X ↗
http://www.sciencedirect.com/science/journal/13866346 ↗
http://www3.interscience.wiley.com/journal/118507311/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=hep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hepr.13746 ↗
- Languages:
- English
- ISSNs:
- 1386-6346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.845000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21213.xml